Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage07:29

Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage

2.1K
The present protocol describes a unique technique called dosage-adjusted resistance training (DART), which can be incorporated into precision rehabilitation studies performed in small animals, such as...
2.1K
Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex06:04

Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex

9.2K
Pain assessment in anesthetized patients who cannot communicate with the outside world in any way remains challenging despite the development of innovative objective pain evaluation tools. In this project, the pupillary dilation reflex and the nociception flexion reflex are assessed in critically ill, mechanically ventilated adult...
9.2K
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

9.9K
Infections caused by multidrug-resistant (MDR) bacterial strains have emerged as a serious threat to public health, necessitating the development of alternative therapeutics. We present a protocol to evaluate the effectiveness of antimicrobial blue light (aBL) therapy for MDR Acinetobacter baumannii infections in mouse burns by using bioluminescence...
9.9K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

87.6K
The NICU Network Neurobehavioral Scale (NNNS) was developed as an assessment for the at-risk infant. The purpose of this article is to describe the NNNS, provide video examples of the NNNS procedures and discuss the ways in which the exam has been...
87.6K
Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

22.7K
In this protocol we demonstrate the expression, solubilization, and purification of a recombinantly expressed membrane protein, MexB, as a soluble protein detergent complex. MexB is a multidrug resistance membrane transporter from the opportunistic bacterial pathogen Pseudomonas aeruginosa.
22.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

19.6K
The microscopic-observation drug-susceptibility (MODS) assay is a low-cost, low-tech tool for high-performance detection of tuberculosis (TB) and multidrug-resistant tuberculosis (MDRTB). This video describes the MODS liquid media culture...
19.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The double threat: bacterial and fungal co-/superinfection in viral pneumonia.

Expert review of respiratory medicine·2026
Same author

Machine Learning-Based Identification of Risk Factors for ICU Mortality in 8902 Critically Ill Patients with Pandemic Viral Infection.

Journal of clinical medicine·2025
Same author

Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study.

Antibiotics (Basel, Switzerland)·2025
Same author

Outcomes and predictors of mortality in patients with severe COVID-19 and COPD admitted to ICU: A multicenter study.

Anaesthesia, critical care & pain medicine·2025
Same author

Surveillance of device-associated infection rates at adult intensive care units in the VINCat program (2010-2022).

Enfermedades infecciosas y microbiologia clinica (English ed.)·2025
Same author

Early bacterial co-infections and ventilator-associated lower respiratory tract infections among intubated patients during the first and second COVID-19 waves: a European comparative cohort study.

Respiratory research·2025

Related Experiment Video

Updated: Jan 20, 2026

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.9K

Risks for multidrug-resistant pathogens in the ICU.

Ignacio Martín-Loeches1, Emili Diaz, Jordi Vallés

  • 1aMultidisciplinary Intensive Care Research Organization, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland bCorporació Sanitária I Universitaria Parc Taulí - Hospital De Sabadell, Institut Universitari UAB, Ciber Enfermedades Respiratorias, Sabadell, Barcelona, Spain.

Current Opinion in Critical Care
|September 5, 2014
PubMed
Summary

Multidrug-resistant organisms (MDROs) present a growing challenge due to complex epidemiology and increasing antibiotic resistance. Understanding MDRO spread and optimizing treatment strategies are crucial for effective prevention and management.

More Related Videos

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

22.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

Related Experiment Videos

Last Updated: Jan 20, 2026

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.9K
Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

22.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • The increasing prevalence and underestimated impact of multidrug-resistant organisms (MDROs) pose a significant global health threat.
  • MDRO epidemiology is complex, driven by factors including antibiotic pressure and patient characteristics, leading to rising antibiotic resistance.

Purpose of the Study:

  • To review the epidemiology of MDROs and discuss current prevention and management strategies.
  • To highlight the importance of antibiotic stewardship and explore challenges in treating community- and healthcare-associated infections.
  • To examine the impact and optimal use of new antibiotics for MDRO infections.

Main Methods:

  • Literature review focusing on MDRO epidemiology and resistance patterns.
  • Analysis of current antibiotic stewardship programs and their effectiveness.
  • Evaluation of strategies for the clinical application of novel antimicrobial agents.

Main Results:

  • Antibiotic stewardship is a key strategy in managing MDROs, though controversies exist regarding community versus healthcare-associated infections.
  • Newer antibiotics are being developed, but their optimal use and impact require further investigation.
  • MDRO infections are associated with prolonged hospital stays and increased healthcare resource utilization.

Conclusions:

  • Further research is needed on healthcare-associated pneumonia heterogeneity and novel drug development for MDROs.
  • Current guidelines may require revision to account for evolving MDRO ecology, patient severity, and resistance trends.
  • Timely and appropriate empiric therapy is essential, necessitating a comprehensive understanding of local resistance patterns and patient factors.